JP2016510768A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510768A5
JP2016510768A5 JP2015561831A JP2015561831A JP2016510768A5 JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5 JP 2015561831 A JP2015561831 A JP 2015561831A JP 2015561831 A JP2015561831 A JP 2015561831A JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5
Authority
JP
Japan
Prior art keywords
crystalline form
form suc
suc
impurities
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015561831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2014/000272 external-priority patent/WO2014138812A1/en
Publication of JP2016510768A publication Critical patent/JP2016510768A/ja
Publication of JP2016510768A5 publication Critical patent/JP2016510768A5/ja
Pending legal-status Critical Current

Links

JP2015561831A 2013-03-15 2014-03-14 抗不安化合物の塩、共結晶及び多形 Pending JP2016510768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798926P 2013-03-15 2013-03-15
US61/798,926 2013-03-15
PCT/AU2014/000272 WO2014138812A1 (en) 2013-03-15 2014-03-14 Salts, co-crystals, and polymorphs of an anxiolytic compound

Publications (2)

Publication Number Publication Date
JP2016510768A JP2016510768A (ja) 2016-04-11
JP2016510768A5 true JP2016510768A5 (enExample) 2017-04-20

Family

ID=51535621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015561831A Pending JP2016510768A (ja) 2013-03-15 2014-03-14 抗不安化合物の塩、共結晶及び多形

Country Status (9)

Country Link
US (2) US9745296B2 (enExample)
EP (1) EP2970247A4 (enExample)
JP (1) JP2016510768A (enExample)
CN (1) CN105492440A (enExample)
AU (2) AU2014231722B2 (enExample)
CA (1) CA2905570A1 (enExample)
HK (1) HK1220191A1 (enExample)
MX (1) MX2015013059A (enExample)
WO (1) WO2014138812A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6688434B2 (en) 2002-02-22 2004-02-10 Ecolab Inc. Conveyor and lubricating apparatus, lubricant dispensing device, and method for applying lubricant to conveyor
CN105541701A (zh) * 2015-12-11 2016-05-04 吉林大学珠海学院 以顺丁烯二酸为前驱体的去铁酮药物共晶及其制备方法
TWI729049B (zh) * 2015-12-15 2021-06-01 以色列商諾發測量儀器股份有限公司 圖案化結構中基於拉曼光譜之測量
WO2019109150A1 (en) * 2017-12-07 2019-06-13 Bionomics Limited Methods of treating agitation
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN114585362B (zh) * 2019-09-23 2024-05-07 生态有限公司 治疗制剂及其用途
AU2023201463A1 (en) * 2023-03-08 2024-09-26 Bionomics Limited Method of treating social anxiety disorder
CN121646412A (zh) * 2023-08-08 2026-03-10 株式会社明治 昼夜节律的调整

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018565A2 (en) * 2003-08-21 2005-03-03 Transoral Pharmaceuticals, Inc. Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
US8293737B2 (en) * 2006-10-16 2012-10-23 Bionomics Limited Anxiolytic compounds
DE102006060598A1 (de) * 2006-12-21 2008-06-26 Merck Patent Gmbh Tetrahydrobenzoisoxazole
GB0706044D0 (en) * 2007-03-28 2007-05-09 Syngenta Ltd C0-Crystals
EP2507242A1 (en) * 2009-12-03 2012-10-10 AstraZeneca AB Co - crystals of a triazolo [4,5 - d]pyrimidine platelet aggregation inhibitor
AU2012222869B2 (en) * 2011-03-02 2015-08-13 Bionomics Limited Methods of treating a disease or condition of the central nervous system
US9133188B2 (en) * 2011-05-12 2015-09-15 Bionomics Limited Methods for preparing naphthyridines
AU2013204159B2 (en) * 2013-03-15 2015-05-07 Bionomics Limited A Crystalline Form of an Anxiolytic Compound

Similar Documents

Publication Publication Date Title
JP2016510768A5 (enExample)
JP2021530565A5 (enExample)
JP2018115191A5 (enExample)
JP2010516681A5 (enExample)
JP2018035160A5 (enExample)
JP2013542261A5 (enExample)
JP2016190843A5 (enExample)
JP2015512942A5 (enExample)
JP2016537346A5 (enExample)
JP2020502092A5 (enExample)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
JP2014501282A5 (enExample)
JP2015078230A5 (enExample)
SI2956452T1 (en) Heterocyclic amides as kinase inhibitors
JP2014506907A5 (enExample)
JP2017528506A5 (enExample)
JP2015516427A5 (enExample)
JP2014530818A5 (enExample)
JP2011088926A5 (enExample)
JP2020502224A5 (enExample)
JP2016529315A5 (enExample)
JP2016510767A5 (enExample)
RU2019105794A (ru) Кристаллогидрат соединения (2s, 3r) -изопропил 2 - (((2- (1,5-диметил-6-оксо-1,6-дигидропиридин-3-ил) -1 - ((тетрагидро-2h-пиран) -4-ил) метил) -1h-бензо [d] имидазол-5-ил) метил) амино) -3-гидроксибутаноат эдисилат
JP2016537326A5 (enExample)
RU2012136148A (ru) Новая кристаллическая форма производного циклопропилбензамида